| |
| |
|
| Insider
Information: |
Mcdade Mark |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
5,912,376 |
|
|
Indirect Shares
|
741,691 |
|
|
| Direct
Value |
$95,879,684 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
6,654,067 |
|
|
| Total
Value |
$95,879,684 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PDL Biopharma Inc |
PDLI |
CEO, Director |
2007-07-20 |
46,275 |
2004-06-04 |
0 |
Premium* |
|
|
Aimmune Therapeutics, Inc. |
AIMT |
Director |
2020-10-13 |
0 |
2015-08-11 |
0 |
Premium* |
|
|
Five Prime Therapeutics Inc |
FPRX |
Director |
2016-10-03 |
12,601 |
2016-10-03 |
0 |
Premium* |
|
|
Icosavax, Inc. |
ICVX |
|
2024-02-19 |
0 |
2024-02-19 |
0 |
Premium* |
|
|
Amplitude Healthcare Acquisition... |
AMHCU |
10% Owner |
2021-09-24 |
5,852,982 |
|
0 |
Premium* |
|
|
Tourmaline Bio |
TRML |
|
2024-01-29 |
518 |
2024-01-29 |
741,691 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ICVX |
Icosavax, Inc. |
See Remarks |
– – – |
2024-02-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,510,228) |
0 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
See Remarks |
– – – |
2024-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(55,786) |
0 |
0 |
- |
|
| TRML |
Tourmaline Bio |
|
– • – |
2024-01-29 |
4 |
B |
$32.50 |
$3,250,000 |
I/I |
100,000 |
448,431 |
0.01 |
- |
|
| TRML |
Tourmaline Bio |
Director |
– • – |
2023-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
518 |
518 |
0 |
- |
|
| TRML |
Tourmaline Bio |
Director |
– • – |
2023-10-19 |
4 |
A |
$0.00 |
$0 |
I/I |
348,431 |
348,431 |
0 |
- |
|
| ICVX |
Icosavax, Inc. |
Director |
– • – |
2022-04-01 |
4 |
B |
$7.10 |
$299,798 |
D/D |
42,225 |
50,243 |
2.39 |
- |
|
| AMHCU |
Amplitude Healthcare Acqu... |
10% Owner |
– – • |
2021-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,852,982 |
|
% |
|
| ICVX |
Icosavax, Inc. |
Former 10% Owner |
– – – |
2021-08-02 |
4 |
B |
$15.00 |
$3,320,265 |
D/D |
221,351 |
3,523,561 |
2.44 |
- |
|
| ICVX |
Icosavax, Inc. |
Former 10% Owner |
– – – |
2021-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,310,228 |
3,310,228 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2020-10-13 |
4 |
D |
$34.50 |
$270,480 |
D/D |
(7,840) |
0 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2020-10-10 |
4 |
D |
$34.50 |
$926,394 |
D/D |
(26,852) |
0 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2020-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
7,840 |
34,692 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,442 |
26,852 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2018-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
20,410 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Director |
– • – |
2016-10-03 |
4 |
OE |
$1.23 |
$17,011 |
D/D |
12,601 |
12,601 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2015-08-11 |
4 |
B |
$16.00 |
$266,560 |
D/D |
16,660 |
16,660 |
2.39 |
- |
|
| PDLI |
PDL Biopharma Inc |
CEO |
• • – |
2007-07-20 |
4 |
D |
$26.22 |
$179,922 |
D/D |
(6,862) |
46,275 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
CEO |
• • – |
2007-01-17 |
4 |
AS |
$21.45 |
$214,523 |
D/D |
(10,000) |
53,137 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
CEO |
• • – |
2007-01-17 |
4 |
OE |
$8.30 |
$83,000 |
D/D |
10,000 |
63,137 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
CEO |
• • – |
2007-01-16 |
4 |
OE |
$8.30 |
$83,000 |
D/D |
10,000 |
63,137 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
CEO |
• • – |
2007-01-16 |
4 |
AS |
$21.27 |
$212,890 |
D/D |
(10,000) |
53,137 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
CEO |
• • – |
2007-01-12 |
4 |
AS |
$20.81 |
$192,264 |
D/D |
(9,200) |
53,137 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
CEO |
• • – |
2007-01-12 |
4 |
S |
$20.80 |
$16,640 |
D/D |
(800) |
54,337 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
CEO |
• • – |
2007-01-12 |
4 |
OE |
$8.30 |
$83,000 |
D/D |
10,000 |
63,137 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
CEO |
• • – |
2007-01-11 |
4 |
AS |
$20.49 |
$207,067 |
D/D |
(10,000) |
53,137 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
